Phathom Pharmaceuticals, Inc. (PHAT)
Across 27 earnings reports since Nov 25, 2019, Phathom Pharmaceuticals, Inc. (PHAT) has a clear post-earnings pattern. It moves ±5.87% on average after reporting and finishes higher 55.6% of the time. Its largest post-earnings gain was +10.06% (Feb 26, 2026) and its largest decline was -28.78% (Aug 02, 2022). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
27
Avg Abs. Movement
±5.87%
Positive %
55.6%
Negative %
44.4%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | ☀ PRE | $11.46 | $11.82 | $11.20 | 4,232,170 | -4.92% | open_in_new |
| Feb 26, 2026 | ☀ PRE | $13.00 | $14.39 | $13.56 | 1,799,300 | +10.06% | open_in_new |
| Oct 30, 2025 | ☀ PRE | $14.00 | $16.08 | $13.31 | 2,531,600 | -1.63% | open_in_new |
| Aug 07, 2025 | ☀ PRE | $9.21 | $10.09 | $9.40 | 2,195,000 | +8.29% | open_in_new |
| May 01, 2025 | ☀ PRE | $4.00 | $4.04 | $3.36 | 5,525,200 | -21.68% | open_in_new |
| Mar 06, 2025 | ☀ PRE | $5.76 | $6.98 | $5.90 | 2,346,300 | -2.96% | open_in_new |
| Nov 07, 2024 | ☀ PRE | $18.78 | $18.80 | $18.50 | 1,358,900 | +2.78% | open_in_new |
| Aug 08, 2024 | ☀ PRE | $11.50 | $12.11 | $11.75 | 1,252,800 | +8.7% | open_in_new |
| May 09, 2024 | ☀ PRE | $9.70 | $11.15 | $10.09 | 1,113,600 | -0.1% | open_in_new |
| Mar 07, 2024 | ☀ PRE | $10.49 | $10.56 | $9.09 | 1,336,500 | -6.58% | open_in_new |
| Nov 09, 2023 | ☀ PRE | $8.38 | $9.04 | $7.86 | 674,900 | +0.51% | open_in_new |
| Aug 10, 2023 | ☽ POST | $15.20 | $15.92 | $15.70 | 1,009,100 | -0.67% | open_in_new |
| May 10, 2023 | ☀ PRE | $12.21 | $12.75 | $12.43 | 372,200 | +3.67% | open_in_new |
| Feb 28, 2023 | ☀ PRE | $9.63 | $9.66 | $8.56 | 346,600 | -11.75% | open_in_new |
| Nov 09, 2022 | ☀ PRE | $9.52 | $10.35 | $9.18 | 176,400 | -7.55% | open_in_new |
| Aug 02, 2022 | ☀ PRE | $8.35 | $8.39 | $6.46 | 973,100 | -28.78% | open_in_new |
| May 10, 2022 | ☀ PRE | $9.00 | $9.35 | $8.21 | 876,900 | -8.06% | open_in_new |
| Mar 01, 2022 | ☽ POST | $18.10 | $18.33 | $18.13 | 69,400 | +2.04% | open_in_new |
| Nov 08, 2021 | ☀ PRE | $23.35 | $23.35 | $22.66 | 200,300 | +1.43% | open_in_new |
| Aug 10, 2021 | ☀ PRE | $32.01 | $34.84 | $32.96 | 223,000 | +2.87% | open_in_new |
| May 11, 2021 | ☀ PRE | $32.04 | $34.17 | $34.09 | 90,300 | +3.4% | open_in_new |
| Mar 30, 2021 | ☽ POST | $36.28 | $37.26 | $36.31 | 61,400 | +3.44% | open_in_new |
| Nov 10, 2020 | ☽ POST | $41.87 | $43.08 | $41.49 | 75,900 | -7.93% | open_in_new |
| Aug 06, 2020 | ☀ PRE | $33.08 | $33.37 | $33.10 | 76,600 | +0.3% | open_in_new |
| May 12, 2020 | ☽ POST | $38.25 | $39.89 | $37.39 | 25,500 | +3.69% | open_in_new |
| Mar 19, 2020 | ☀ PRE | $25.65 | $27.94 | $26.88 | 147,500 | +0.11% | open_in_new |
| Nov 25, 2019 | ☀ PRE | $23.21 | $25.87 | $24.55 | 85,100 | +4.6% | open_in_new |
Earnings Count
27
Total earnings in dataset
Avg Abs. Movement
±5.87%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260527 | open_in_new SEC.gov |
| 4 | 20260521 | open_in_new SEC.gov |
| 4 | 20260521 | open_in_new SEC.gov |
| 4 | 20260521 | open_in_new SEC.gov |
| 4 | 20260521 | open_in_new SEC.gov |
| 4 | 20260521 | open_in_new SEC.gov |
| 4 | 20260521 | open_in_new SEC.gov |
| 4 | 20260521 | open_in_new SEC.gov |
| 8-K | 20260521 | open_in_new SEC.gov |
| 10-Q | 20260430 | open_in_new SEC.gov |
Frequently asked about PHAT earnings
When does Phathom Pharmaceuticals, Inc. report earnings next? expand_more
Phathom Pharmaceuticals, Inc. (PHAT)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does PHAT stock move after earnings? expand_more
Over 27 reports, PHAT has moved an average of ±5.87% the session after earnings, closing higher 55.6% of the time.
What was PHAT's biggest post-earnings move? expand_more
PHAT's largest post-earnings gain on record was +10.06% on Feb 26, 2026, and its largest decline was -28.78% on Aug 02, 2022.
Where can I find Phathom Pharmaceuticals, Inc.'s SEC filings? expand_more
All of Phathom Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right